(Q43571155)

24 November 2017

Sequential combination chemotherapy (CABOPP/VIM) for the treatment of high-grade malignant non-Hodgkin lymphoma (English)

1 reference

24 November 2017

Nowrousian MR

1

1 reference

24 November 2017

Meier CR

2

1 reference

24 November 2017

Schoetensack B

3

1 reference

24 November 2017

Anders C

4

1 reference

24 November 2017

Höffken K

5

1 reference

24 November 2017

Osieka R

6

1 reference

24 November 2017

Schmidt CG

7

1 reference

24 November 2017

1 January 1989

1 reference

24 November 2017

1 reference

24 November 2017

28

1 reference

24 November 2017

495-500

1 reference

24 November 2017

4

1 reference

Drugs 5 years later: procarbazine

24 November 2017

1 reference

https://api.crossref.org/works/10.3109%2F02841868909092257

Sequential chemotherapy and late intensification for malignant lymphomas of aggressive histologic type.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841868909092257

Continuous infusion vincristine and bleomycin with high dose methotrexate for resistant non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841868909092257

Clinical pharmacologic and therapeutic studies of bleomycin given by continuous infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841868909092257

Advanced diffuse histiocytic lymphoma, a potentially curable disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841868909092257

Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841868909092257

Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841868909092257

10.3109/02841868909092257

21 January 2018

Identifiers

DOI

1 reference

24 November 2017

1 reference